Carl Zeiss Meditec AG (ETR:AFX)

Market Cap	2.79B -26.1%
Revenue (ttm)	2.18B +0.1%
Net Income	121.51M -19.1%
EPS	1.39 -18.7%
Shares Out	87.54M
PE Ratio	22.89
Forward PE	21.24
Dividend	0.55 (1.71%)
Ex-Dividend Date	Mar 27, 2026

Volume	226,515
Open	31.90
Previous Close	31.92
Day's Range	31.28 - 32.38
52-Week Range	22.62 - 48.36
Beta	1.35
Analysts	Hold
Price Target	27.24 (-12.92%)
Earnings Date	Aug 6, 2026

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: AFX

Financial Performance

In fiscal year 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.

Analyst Summary

According to 15 analysts, the average rating for AFX stock is "Hold." The 12-month stock price target is €27.24, which is a decrease of -12.92% from the latest price.

Price Target

€27.24

(-12.92% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error